• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Natural underlying mtDNA heteroplasmy as a potential source of intra-person hiPSC variability.自然存在的线粒体DNA异质性作为人诱导多能干细胞个体内变异性的潜在来源。
EMBO J. 2016 Sep 15;35(18):1979-90. doi: 10.15252/embj.201694892. Epub 2016 Jul 19.
2
Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS.由 MELAS 患者诱导多能干细胞克隆中分离出的致病线粒体异质性。
Stem Cells. 2013 Jul;31(7):1298-308. doi: 10.1002/stem.1389.
3
mRNA Reprogramming of T8993G Leigh's Syndrome Fibroblast Cells to Create Induced Pluripotent Stem Cell Models for Mitochondrial Disorders.T8993G Leigh 综合征成纤维细胞的 mRNA 重编程,用于创建线粒体疾病的诱导多能干细胞模型。
Stem Cells Dev. 2019 Jul 1;28(13):846-859. doi: 10.1089/scd.2019.0045. Epub 2019 May 20.
4
iPSC culture expansion selects against putatively actionable mutations in the mitochondrial genome.iPSC 培养扩增会选择针对线粒体基因组中假定可采取行动的突变。
Stem Cell Reports. 2021 Oct 12;16(10):2488-2502. doi: 10.1016/j.stemcr.2021.08.016. Epub 2021 Sep 23.
5
Induced pluripotent stem cells derived from patients carrying mitochondrial mutations exhibit altered bioenergetics and aberrant differentiation potential.由携带线粒体突变的患者衍生的诱导多能干细胞表现出改变的生物能量学和异常的分化潜能。
Stem Cell Res Ther. 2023 Nov 7;14(1):320. doi: 10.1186/s13287-023-03546-7.
6
Oocyte mitochondrial deletions and heteroplasmy in a bovine model of ageing and ovarian stimulation.衰老和卵巢刺激牛模型中的卵母细胞线粒体缺失与异质性
Mol Hum Reprod. 2016 Apr;22(4):261-71. doi: 10.1093/molehr/gaw003. Epub 2016 Jan 20.
7
Very low-level heteroplasmy mtDNA variations are inherited in humans.人类遗传非常低水平的异质体 mtDNA 变异。
J Genet Genomics. 2013 Dec 20;40(12):607-15. doi: 10.1016/j.jgg.2013.10.003. Epub 2013 Dec 8.
8
Induced pluripotent stem cells with a mitochondrial DNA deletion.具有线粒体 DNA 缺失的诱导多能干细胞。
Stem Cells. 2013 Jul;31(7):1287-97. doi: 10.1002/stem.1354.
9
Human induced pluripotent stem cells harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining human embryonic stem cell-like metabolic reprogramming.人类诱导多能干细胞在保持人类胚胎干细胞样代谢重编程的同时,携带有同质和异质的线粒体 DNA 突变。
Stem Cells. 2011 Sep;29(9):1338-48. doi: 10.1002/stem.683.
10
The relevance of mitochondrial DNA variants fluctuation during reprogramming and neuronal differentiation of human iPSCs.线粒体 DNA 变异在人诱导多能干细胞重编程和神经元分化过程中的相关性。
Stem Cell Reports. 2021 Aug 10;16(8):1953-1967. doi: 10.1016/j.stemcr.2021.06.016. Epub 2021 Jul 29.

引用本文的文献

1
Recommendations, guidelines, and best practice for the use of human induced pluripotent stem cells for neuropharmacological studies of neuropsychiatric disorders.关于使用人类诱导多能干细胞进行神经精神疾病神经药理学研究的建议、指南和最佳实践。
Neurosci Appl. 2023 Mar 20;2:101125. doi: 10.1016/j.nsa.2023.101125. eCollection 2023.
2
Mitochondrial DNA integrity and metabolome profile are preserved in the human induced pluripotent stem cell reference line KOLF2.1J.人诱导多能干细胞参考系 KOLF2.1J 中保留了线粒体 DNA 完整性和代谢组特征。
Stem Cell Reports. 2024 Mar 12;19(3):343-350. doi: 10.1016/j.stemcr.2024.01.009. Epub 2024 Feb 22.
3
Challenges and opportunities to bridge translational to clinical research for personalized mitochondrial medicine.实现个性化线粒体医学转化到临床研究的挑战和机遇。
Neurotherapeutics. 2024 Jan;21(1):e00311. doi: 10.1016/j.neurot.2023.e00311. Epub 2024 Jan 19.
4
Induced pluripotent stem cells: ex vivo models for human diseases due to mitochondrial DNA mutations.诱导多能干细胞:源于线粒体 DNA 突变的人类疾病的体外模型。
J Biomed Sci. 2023 Sep 22;30(1):82. doi: 10.1186/s12929-023-00967-7.
5
The Mitochondrial m.3243A>G Mutation on the Dish, Lessons from In Vitro Models.线粒体 m.3243A>G 突变在体外模型中的启示。
Int J Mol Sci. 2023 Aug 30;24(17):13478. doi: 10.3390/ijms241713478.
6
Novel economical, accurate, sensitive, single-cell analytical method for mitochondrial DNA quantification in mtDNA mutation carriers.用于 mtDNA 突变携带者中线粒体 DNA 定量的新型经济、准确、敏感的单细胞分析方法。
J Assist Reprod Genet. 2023 Sep;40(9):2197-2209. doi: 10.1007/s10815-023-02878-w. Epub 2023 Jul 18.
7
Amphipathic Liponecrosis Impairs Bacterial Clearance and Causes Infection During Sterile Inflammation.两亲性脂肪坏死会损害细菌清除并在无菌性炎症期间导致感染。
Gastroenterology. 2023 Oct;165(4):999-1015. doi: 10.1053/j.gastro.2023.05.034. Epub 2023 May 30.
8
Role of mitochondrial stress and the NLRP3 inflammasome in lung diseases.线粒体应激和 NLRP3 炎性体在肺部疾病中的作用。
Inflamm Res. 2023 Apr;72(4):829-846. doi: 10.1007/s00011-023-01712-4. Epub 2023 Mar 11.
9
Modeling mitochondrial DNA diseases: from base editing to pluripotent stem-cell-derived organoids.建模线粒体 DNA 疾病:从碱基编辑到多能干细胞衍生的类器官。
EMBO Rep. 2023 Apr 5;24(4):e55678. doi: 10.15252/embr.202255678. Epub 2023 Mar 6.
10
siVAE: interpretable deep generative models for single-cell transcriptomes.siVAE:单细胞转录组的可解释深度生成模型。
Genome Biol. 2023 Feb 20;24(1):29. doi: 10.1186/s13059-023-02850-y.

本文引用的文献

1
Age-Related Accumulation of Somatic Mitochondrial DNA Mutations in Adult-Derived Human iPSCs.年龄相关的体细胞线粒体 DNA 突变在成人来源的人类诱导多能干细胞中的积累。
Cell Stem Cell. 2016 May 5;18(5):625-36. doi: 10.1016/j.stem.2016.02.005. Epub 2016 Apr 14.
2
Metabolic rescue in pluripotent cells from patients with mtDNA disease.多能细胞中线粒体 DNA 疾病患者的代谢挽救。
Nature. 2015 Aug 13;524(7564):234-8. doi: 10.1038/nature14546. Epub 2015 Jul 15.
3
Mitochondrial respiratory dysfunction caused by a heteroplasmic mitochondrial DNA mutation blocks cellular reprogramming.异质性线粒体DNA突变引起的线粒体呼吸功能障碍会阻碍细胞重编程。
Hum Mol Genet. 2015 Aug 15;24(16):4698-709. doi: 10.1093/hmg/ddv201. Epub 2015 May 29.
4
Mechanisms linking mtDNA damage and aging.连接线粒体DNA损伤与衰老的机制。
Free Radic Biol Med. 2015 Aug;85:250-8. doi: 10.1016/j.freeradbiomed.2015.05.005. Epub 2015 May 13.
5
Generating iPSCs: translating cell reprogramming science into scalable and robust biomanufacturing strategies.生成诱导多能干细胞:将细胞重编程科学转化为可扩展和稳健的生物制造策略。
Cell Stem Cell. 2015 Jan 8;16(1):13-7. doi: 10.1016/j.stem.2014.12.013.
6
Extensive pathogenicity of mitochondrial heteroplasmy in healthy human individuals.健康人体中线粒体异质性的广泛致病性。
Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):10654-9. doi: 10.1073/pnas.1403521111. Epub 2014 Jul 7.
7
Chemically defined generation of human cardiomyocytes.化学定义的人类心肌细胞生成。
Nat Methods. 2014 Aug;11(8):855-60. doi: 10.1038/nmeth.2999. Epub 2014 Jun 15.
8
Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management.线粒体心肌病:病理生理学、诊断与管理
Tex Heart Inst J. 2013;40(4):385-94.
9
Tissue- and cell-type-specific manifestations of heteroplasmic mtDNA 3243A>G mutation in human induced pluripotent stem cell-derived disease model.人类诱导多能干细胞衍生疾病模型中线粒体 DNA 3243A>G 突变的组织和细胞类型特异性表现。
Proc Natl Acad Sci U S A. 2013 Sep 17;110(38):E3622-30. doi: 10.1073/pnas.1311660110. Epub 2013 Sep 3.
10
Clonal genetic and hematopoietic heterogeneity among human-induced pluripotent stem cell lines.人类诱导多能干细胞系中的克隆遗传和造血异质性。
Blood. 2013 Sep 19;122(12):2047-51. doi: 10.1182/blood-2013-02-484444. Epub 2013 Aug 12.

自然存在的线粒体DNA异质性作为人诱导多能干细胞个体内变异性的潜在来源。

Natural underlying mtDNA heteroplasmy as a potential source of intra-person hiPSC variability.

作者信息

Perales-Clemente Ester, Cook Alexandra N, Evans Jared M, Roellinger Samantha, Secreto Frank, Emmanuele Valentina, Oglesbee Devin, Mootha Vamsi K, Hirano Michio, Schon Eric A, Terzic Andre, Nelson Timothy J

机构信息

Departments of Medicine, Molecular Pharmacology and Experimental Therapeutics, and Medical Genetics, Division of Cardiovascular Diseases, Mayo Clinic Center for Regenerative Medicine, Rochester, MN, USA.

Departments of Cardiovascular Diseases, Molecular Pharmacology and Experimental Therapeutics, Division of General Internal Medicine, Division of Pediatric Cardiology, and Transplant Center, Mayo Clinic Center for Regenerative Medicine, Rochester, MN, USA.

出版信息

EMBO J. 2016 Sep 15;35(18):1979-90. doi: 10.15252/embj.201694892. Epub 2016 Jul 19.

DOI:10.15252/embj.201694892
PMID:27436875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5282833/
Abstract

Functional variability among human clones of induced pluripotent stem cells (hiPSCs) remains a limitation in assembling high-quality biorepositories. Beyond inter-person variability, the root cause of intra-person variability remains unknown. Mitochondria guide the required transition from oxidative to glycolytic metabolism in nuclear reprogramming. Moreover, mitochondria have their own genome (mitochondrial DNA [mtDNA]). Herein, we performed mtDNA next-generation sequencing (NGS) on 84 hiPSC clones derived from a cohort of 19 individuals, including mitochondrial and non-mitochondrial patients. The analysis of mtDNA variants showed that low levels of potentially pathogenic mutations in the original fibroblasts are revealed through nuclear reprogramming, generating mutant hiPSCs with a detrimental effect in their differentiated progeny. Specifically, hiPSC-derived cardiomyocytes with expanded mtDNA mutations non-related with any described human disease, showed impaired mitochondrial respiration, being a potential cause of intra-person hiPSC variability. We propose mtDNA NGS as a new selection criterion to ensure hiPSC quality for drug discovery and regenerative medicine.

摘要

诱导多能干细胞(hiPSC)的人类克隆之间的功能变异性仍然是构建高质量生物样本库的一个限制因素。除了个体间的变异性外,个体内变异性的根本原因仍然未知。线粒体在核重编程过程中引导着从氧化代谢到糖酵解代谢的必要转变。此外,线粒体有自己的基因组(线粒体DNA [mtDNA])。在此,我们对来自19名个体(包括线粒体和非线粒体疾病患者)群体的84个hiPSC克隆进行了mtDNA下一代测序(NGS)。mtDNA变异分析表明,通过核重编程可揭示原始成纤维细胞中低水平的潜在致病突变,从而产生对其分化后代有有害影响的突变hiPSC。具体而言,具有与任何已描述人类疾病无关的mtDNA突变扩展的hiPSC来源的心肌细胞,显示出线粒体呼吸受损,这是个体内hiPSC变异性的一个潜在原因。我们建议将mtDNA NGS作为一种新的选择标准,以确保用于药物发现和再生医学的hiPSC质量。